ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in Orlando, FL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Carcinoma
Hypersensitivity
Adenocarcinoma
Recurrence
Breast Cancer

Prostate Cancer trials near Orlando, FL, USA:

PET Scan Study to Detect Prostate Cancer in Patients With Early PSA Recurrence

agent for use with positron emission tomography (PET) imaging for prostate cancer.The research is being done to study the capabilit ...

Enrolling
Prostate Cancer (Post Prostatectomy)
Drug: 18F-rhPSMA-7.3 (Posluma)

Phase 2

AdventHealth
AdventHealth

Orlando, Florida, United States

A Phase 1/2 study to evaluate the safety and efficacy of ARV-766 given by mouth alone or in combination with abiraterone in men with metastatic prostate...

Enrolling
Prostate Cancer Metastatic
Drug: ARV-766 + Abiraterone Part C&D
Drug: ARV-766 Part A&B

Phase 1, Phase 2

Arvinas
Arvinas

Lake Mary, Florida, United States and 22 other locations

Phase 1/2 dose escalation study to assess the safety and tolerability of ARV-110 in men with mCRPC who have progressed on prior approved systemic the...

Active, not recruiting
Prostate Cancer Metastatic
Drug: ARV-110

Phase 1, Phase 2

Arvinas
Arvinas

Orlando, Florida, United States and 53 other locations

Prostate cancer has the second highest incidence rate and is the fifth leading cause of cancer-related deaths among men wo ...

Enrolling
Metastatic Castration-Resistant Prostate Cancer
Drug: ABBV-969

Phase 1

AbbVie
AbbVie

Orlando, Florida, United States and 16 other locations

Phase 3 Trial Comparing the Safety and Efficacy of 177Lu-PSMA-I\&T versus Hormone Therapy in Patients with Metastatic Castration-Resistant Prostate...

Active, not recruiting
Metastasis From Malignant Tumor of Prostate
Drug: 177Lu-PSMA-I&T
Drug: Abiraterone with Prednisone or Enzalutamide

Phase 3

Curium

Orlando, Florida, United States and 51 other locations

The purpose of this study is to evaluate the efficacy and safety of apalutamide in adult men with high-risk non-metastatic castration-resistant prostate...

Active, not recruiting
Prostatic Neoplasms
Drug: Apalutamide
Drug: Placebo

Phase 3

Aragon Pharmaceuticals

Orlando, Florida, United States and 388 other locations

activity of RO7656594 in participants with advanced or metastatic prostate cancer. It will also identify recommended doses and regi...

Enrolling
Metastatic Prostate Cancer
Advanced Prostate Cancer
Drug: RO7656594

Phase 1

Genentech
Genentech

Orlando, Florida, United States and 11 other locations

plus docetaxel in participants with metastatic castration resistant prostate cancer (mCRPC), all participants will receive the doce...

Enrolling
Prostate Cancer
Drug: docetaxel
Other: placebo

Phase 3

AstraZeneca
AstraZeneca

Orange City, Florida, United States and 251 other locations

be prolonged in participants with metastatic castration-resistant prostate cancer (MCRPC) who receive lorigerlimab in addition to t...

Enrolling
Prostate Cancer Recurrent
Androgen-Resistant Prostatic Cancer
Drug: docetaxel
Drug: Prednisone

Phase 2

MacroGenics
MacroGenics

Orlando, Florida, United States and 60 other locations

Researchers are looking for a better way to treat men at high-risk of biochemical recurrence (BCR) of prostate cancer.BCR means tha ...

Enrolling
Biochemically Recurrent Prostate Cancer
Other: Placebo matching darolutamide
Drug: Darolutamide (BAY1841788, Nubeqa)

Phase 3

Bayer
Bayer

Clermont, Florida, United States and 295 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems